Action GHSI GUARDION HEALTH SCIENCES, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Guardion Health Sciences, Inc.

Actions

GHSI

US40145Q5009

Temps Différé Nasdaq
Autres places de cotation
 17:44:01 10/06/2024 		Varia. 5j. Varia. 1 janv.
9,85 USD -0,51 % Graphique intraday de Guardion Health Sciences, Inc. +2,60 % +84,46 %
31/05 Doctor's Best, Inc. a complété l'acquisition d'Activ Nutritional, LLC. de Guardion Health Sciences, Inc. (NasdaqCM:GHSI). CI
13/05 Guardion Health Sciences, Inc. déclare ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution
AQ
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business
AQ
Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024
AQ
Guardion Health Sciences Announces
AQ
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
AQ
Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.
AQ
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
AQ
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023
AQ
GUARDION HEALTH SCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer
AQ
Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023
AQ
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022
AQ
GUARDION HEALTH SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
GUARDION HEALTH SCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value
AQ
GUARDION HEALTH SCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements
AQ
GUARDION HEALTH SCIENCES, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023
AQ
GUARDION HEALTH SCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action GHSI
  4. Actualités Guardion Health Sciences, Inc.
  5. Communiqués